Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 9/20 | 0.56 |
| ▸ | NPY4R | P50391 | 2/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.47 |
| ▸ | HRAS | P01112 | 1/20 | 0.47 |
| ▸ | KRAS | P01116 | 1/20 | 0.47 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.45 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.45 |
| ▸ | BECN1 | Q14457 | 1/20 | 0.45 |
| ▸ | TFPI | P10646 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.44 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19682181 | 0.91 | NMUR2 (0.52) | NTSR2NPY4RNPY1RNPY2RNMUR2 | |
| SCHEMBL30446151 | 0.88 | NMUR2 (0.67) | NTSR2NPY1RNMUR2NTSR1NMUR1 | |
| SCHEMBL38650581 | 0.86 | KDM1A (0.62) | NPY4RNPY1RNPY2RNMUR2NMUR1 | |
| SCHEMBL9652970 | 0.82 | NTSR2 (0.57) | NTSR2NPY4RNPY1RNPY2RSRC | |
| SCHEMBL31430950 | 0.82 | NPY4R (0.54) | NTSR2NPY4RNPY1RNPY2RNMUR2 | |
| SCHEMBL30512662 | 0.82 | NPY4R (0.62) | NPY4RNPY1RNPY2R | |
| SCHEMBL10938992 | 0.82 | KDM1A (0.49) | NTSR2NPY4RNPY1RNPY2RHRAS | |
| SCHEMBL30483715 | 0.81 | NTSR2 (0.43) | NTSR2SRC | |
| Glaspimod SCHEMBL609834 | 0.81 | FOLH1 (0.48) | — | |
| SCHEMBL30717622 | 0.80 | NMUR2 (0.50) | NTSR2NPY4RNPY1RNPY2RNMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250154219-A1 | PEPTIDE ANALOGS | ADEPTHERA LLC | 2025-05-15 | — | — | US | disclosed |
| US-12110318-B2 | Peptide analogs | ADEPTHERA LLC (US) | 2024-10-08 | — | — | US | disclosed |
| US-20220324935-A1 | PEPTIDE ANALOGS | ADEPTHERA LLC | 2022-10-13 | — | — | US | disclosed |
| US-11390657-B2 | Peptide analogs | ADEPTHERA LLC (US) | 2022-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12110318-B2 | Peptide analogs | RAMP1, RAMP3, RAMP2 | NTSR2 25/4885NPY4R 182/4885NPY1R 119/4885 |
| US-20220324935-A1 | PEPTIDE ANALOGS | RAMP1, RAMP2, RAMP3 | NTSR2 44/4885NPY4R 255/4885NPY1R 115/4885 |
| US-20250154219-A1 | PEPTIDE ANALOGS | RAMP1, RAMP2, RAMP3 | NTSR2 44/4885NPY4R 255/4885NPY1R 115/4885 |
| US-11390657-B2 | Peptide analogs | RAMP1, RAMP3, RAMP2 | NTSR2 25/4885NPY4R 182/4885NPY1R 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.